Yates M,Watts RA,Bajema IM,Cid MC,Crestani B,Hauser T .2016 .ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis, 10(9) : 1583-94.
Chevet B,Cornec D,Moura MC,Gall ECL,Fervenza FC,Warrington KJ .2023 .Diagnosing and treating ANCAassociated vasculitis: An updated review for clinical practice. Rheumatology, 10(5) : 1787-803.
Groh M,Pagnoux C,Baldini C,Bel E,Bottero P,Cottin V .2015 .Eosinophilic granulomatosis with polyangiitis (ChurgStrauss) (EGPA) consensus task force recommendations for evaluation and management. Eur J Intern Med, 04(7) : 545-3.
Robson JC,Grayson PC,Ponte C,Suppiah R,Craven A,Judge A .2022 .American College of Rheumatology/European Alliance of Associations for Rheumatology classi cation criteria for granulomatosis with polyangiitis. Ann Rheum Dis, 10(3) : 315-20.
Suppiah R,Robson JC,Grayson PC,Ponte C,Craven A,Khalid S .2022 .American college of rheumatology/European alliance of associations for rheumatology classi cation criteria for microscopic polyangiitis. Ann Rheum Dis, 10(3) : 321-6.
Frohnert PP,Sheps SG PP .1967 .Long-term follow-up study of periarteritis nodosa. Am J Med, 10(67) : 90144-1.
Hellmich B,Alamo BS,Schirmer JH,Berti A,Blockmans D,Cid MC .2024 .EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis, 10(1) : 30-47.
Thietart S,Karras A,Augusto JF,Philipponnet C,Carron PL,Delbrel X .2022 .Evaluation of rituximab for induction and maintenance therapy in patients 75 years and older with antineutrophil cytoplasmic antibody-associated vasculitis. JAMA Netw Open, 20925(7) : .
Moura MC,Irazabal MV,Eirin A,Zand L,Sethi S,Borah BJ .2020 .E cacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis with severe kidney disease. J Am Soc Nephrol, 10(11) : 2688-704.
de Groot K,Harper L,Jayne DR,Gregorini G,Gross WL .2009 .Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibodyassociated vasculitis: A randomised trial. Ann Intern Med, 10(10) : 0003-80.
Villanueva FB,Loricera J,Rio VC,Selaya CC,Castaneda S,Blanco R .2023 .Intravenous immunoglobulin therapy in antineutrophil cytoplasmic antibody-associated vasculitis. Eur J Intern Med, 06 : 78-84.
Koike H,Nishi R,Ohyama K,Morozumi S,Kawagashira Y,Furukawa S .2022 .ANCA-associated vasculitic neuropathies: A review. Neurol Ther, 10(1) : 21-38.
Yates M,Watts R,Bajema I,Cid M,Crestani B,Hauser T .2017 .3(1):e000449. RMD open, 10 : .
Walsh M,Faurschou M,Berden A,Flossmann O,Bajema I,Hoglund P .2014 .Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis. Clin J Am Soc Nephrol, 10(9) : 1571-6.
Terrier B,Pagnoux C,Perrodeau E,Karras A,Khouatra C,Aumaitre O .2018 .et a.l Long-term e cacy of remission-maintenance regimens for ANCA-associated vasculitidesA. nn Rheum Dis, 10(8) : 212768-6.
Smith RM,Jones RB,Specks U,Bond S,Nodale M,Al-Jayyousi R .2023 .Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: An international randomised controlled trial. Ann Rheum Dis, 10(7) : 223559-44.
Pagnoux C,Mahr A,Hamidou MA,Ruivard JJ,Ducroix M,JP M .2008 .Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. New Engl J Med, 10(26) : 2790-803.
Maritati F,Alberici F,Oliva E,Urban ML,Palmisano A,Santarsia F .2017 .Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial. PloS One, 0185880(10) : .
Jayne D,Rasmussen N,Andrassy K,Bacon P,Tervaert JWC,Dadoniene J .2003 .A randomised trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. New Engl J Med, 10(1) : 36-44.
Jayne D,Blockmans D,Luqmani R,Moiseev S,Ji B,Green Y .2019 .E cacy and safety of belimumab and azathioprine for maintenance of remission in antineutrophil cytoplasmic antibody-associated vasculitis: A randomised controlled study. Arthritis Rheumatol, 10(6) : 952-63.
Hiemstra TF,Walsh M,Mahr A,Savage CO,de Groot K,Harper L .2010 .Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: A randomised controlled trial. JAMA, 1658(21) : 2381-8.
Guillevin L,Pagnoux C,Karras A,Khouatra C,Aumaitre O,Cohen P .2014 .Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. New Engl J Med, 10(19) : 1771-80.
Hutton B,Salanti G,Caldwell DM,Chaimani A,Schmid CH,Cameron C .2015 .The PRISMA extension statement for reporting of systematic reviews incorporating network metaanalyses of health care interventions: Checklist and explanations. Ann Intern Med, 10(11) : 2385-84.
Higgins JP,Altman DG,Gotzsche PC,Moher D,Oxman AD .2011 .The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ, 10 : .
Wei A,Gu Z,Li J,Liu X,Wu X,Han Y .2016 .Clinical adverse e ects of endothelin receptor antagonists: Insights from the meta-analysis of 4894 patients from 24 randomised doubleblind placebo-controlled clinical trials. J Am Heart Assoc, 10(11) : .
Chaimani A,Higgins JP,Mavridis D,Spyridonos P,Salanti G .2013 .Graphical tools for network meta-analysis in STATA. PloS One, 0076654(10) : .
Wang YB,Cui YX,Song JN,Yang Q,Wang G. .2018 .E cacies of various surgical regimens in the treatment of renal calculi patients: A network meta-analysis in 25 enrolled controlled clinical trials. Kidney Blood Press Res, 43(4) : 1183-98.
. .. doi: 10, : .
Higgins JP,Jackson D,Barrett JK,Lu G,Ades AE,White IR .2012 .Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods, 10(2) : 98-110.
White IR,Barrett JK,Jackson D,Higgins JP .2012 .Consistency and inconsistency in network meta-analysis: Model estimation using multivariate meta-regression. Res Synth Methods, 10(2) : 111-25.
Wan X,Wang W,Liu J,Tong T. Estimating .2014 .the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol, 10 : 1471.
Hozo SP,Djulbegovic B,Hozo I. Estimating .2005 .the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol, 10 : 1471.
Mbuagbaw L,Rochwerg B,Jaeschke R,Andsell DH,Alhazzani W,Thabane L .2017 .Approaches to interpreting and choosing the best treatments in network meta-analyses. Syst Rev, 10(1) : 79.
Ross C,Makhzoum JP,Pagnoux C. .2022 .Updates in ANCAassociated vasculitis. Eur J Rheumatol, 20248(3) : 153-66.
Sattui SE,Spiera RF .2019 .Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: Is there still a role for cyclophosphamide?. Rheum Dis Clin North Am, 04(3) : 379-98.
Monti S,Brandolino F,Milanesi A,Xoxi B,Delvino P,Montecucco C .2021 .Novel therapies for ANCA-associated vasculitis. Curr Rheumatol Rep, 10(6) : 38.
Salvador F. .2020 .ANCA associated vasculitis. Eur J Intern Med, 01 : 18-28.
Lee YH,Song GG .2022 .Comparative e cacy and safety of rituximab, mycophenolate, methotrexate, and cyclophosphamide versus azathioprine as maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomised controlled trials. Int J Clin Pharmacol Ther, 10(2) : 97-105.